Median age of patients who experienced chemotherapy related AKI was 1.50 years (IQR 1.00-6.75 years) and they were younger then patients who did not developed CIS or IFO induced AKI (median age 6.00 years; IQR 2.25-14.00 years), but that difference did not reach statistical significance (Table 1 ).
← all excerpts
Urinary biomarkers in prediction of subclinical acute kidney injury in pediatric oncology patients treated with nephrotoxic agents.
1
—
—